Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Koerber

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The Annals of Pharmacotherapy|May 30, 2003
Comparing methods of establishing the aPTT therapeutic range of heparinClaire I Liepman, John M Koerber, Joan C Mattson, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 18, 2017
Characteristics, Management, and Outcomes of Patients with Atrial Fibrillation Experiencing a Major Bleeding Event While on RivaroxabanKaren D Burgos, Sarah E Sienko, Janet L Hoffman, et al.
Pharmacotherapy|August 25, 2009
Argatroban dosage requirements and outcomes in intensive care versus non-intensive care patientsMaureen A Smythe, John M Koerber, Lisa L Forsyth, et al.
Journal of Thrombosis and Thrombolysis|April 9, 2015
Dabigatran versus warfarin major bleeding in practice: an observational comparison of patient characteristics, management and outcomes in atrial fibrillation patientsMaureen A Smythe, Michael J Forman, Elizabeth A Bertran, et al.
Thrombosis Research|September 4, 2021
Outcomes of activated prothrombin complex concentrate for direct Xa inhibitor bleedingMaureen A Smythe, John M Koerber, Janet L Hoffman, et al.
The Annals of Pharmacotherapy|January 31, 2002
Correlation between activated clotting time and activated partial thromboplastin timesMaureen A Smythe, John M Koerber, Sandra N Nowak, et al.
Thrombosis and Haemostasis|September 8, 2012
Assessing the impact of a heparin-induced thrombocytopenia protocol on patient management, outcomes and costMaureen A Smythe, John M Koerber, Trupti P Mehta, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 21, 2012
Development and implementation of a comprehensive heparin-induced thrombocytopenia recognition and management protocolMaureen A Smythe, Trupti P Mehta, John M Koerber, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The Annals of Pharmacotherapy|May 30, 2003
Comparing methods of establishing the aPTT therapeutic range of heparinClaire I Liepman, John M Koerber, Joan C Mattson, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 18, 2017
Characteristics, Management, and Outcomes of Patients with Atrial Fibrillation Experiencing a Major Bleeding Event While on RivaroxabanKaren D Burgos, Sarah E Sienko, Janet L Hoffman, et al.
Pharmacotherapy|August 25, 2009
Argatroban dosage requirements and outcomes in intensive care versus non-intensive care patientsMaureen A Smythe, John M Koerber, Lisa L Forsyth, et al.
Journal of Thrombosis and Thrombolysis|April 9, 2015
Dabigatran versus warfarin major bleeding in practice: an observational comparison of patient characteristics, management and outcomes in atrial fibrillation patientsMaureen A Smythe, Michael J Forman, Elizabeth A Bertran, et al.
Thrombosis Research|September 4, 2021
Outcomes of activated prothrombin complex concentrate for direct Xa inhibitor bleedingMaureen A Smythe, John M Koerber, Janet L Hoffman, et al.
The Annals of Pharmacotherapy|January 31, 2002
Correlation between activated clotting time and activated partial thromboplastin timesMaureen A Smythe, John M Koerber, Sandra N Nowak, et al.
Thrombosis and Haemostasis|September 8, 2012
Assessing the impact of a heparin-induced thrombocytopenia protocol on patient management, outcomes and costMaureen A Smythe, John M Koerber, Trupti P Mehta, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 21, 2012
Development and implementation of a comprehensive heparin-induced thrombocytopenia recognition and management protocolMaureen A Smythe, Trupti P Mehta, John M Koerber, et al.
Pageof 2